CATALOGO DEI PRODOTTI DELLA RICERCA

Maggino, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.392
EU - Europa 1.911
AS - Asia 1.693
SA - Sud America 257
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 6.305
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.360
CN - Cina 653
SG - Singapore 652
GB - Regno Unito 470
IT - Italia 241
RU - Federazione Russa 229
BR - Brasile 217
DE - Germania 216
HK - Hong Kong 210
FR - Francia 196
IE - Irlanda 185
SE - Svezia 162
FI - Finlandia 77
KR - Corea 58
UA - Ucraina 40
JP - Giappone 30
NL - Olanda 24
CA - Canada 17
VN - Vietnam 16
BE - Belgio 15
IN - India 15
AR - Argentina 13
MX - Messico 11
TG - Togo 11
BD - Bangladesh 10
DZ - Algeria 10
ID - Indonesia 9
PL - Polonia 9
TR - Turchia 8
AT - Austria 7
CZ - Repubblica Ceca 6
CO - Colombia 5
EC - Ecuador 5
ES - Italia 5
MA - Marocco 5
ZA - Sudafrica 5
PE - Perù 4
PY - Paraguay 4
UZ - Uzbekistan 4
AL - Albania 3
AU - Australia 3
CL - Cile 3
EU - Europa 3
GR - Grecia 3
IL - Israele 3
IQ - Iraq 3
KG - Kirghizistan 3
NO - Norvegia 3
PT - Portogallo 3
SA - Arabia Saudita 3
UG - Uganda 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
EG - Egitto 2
HU - Ungheria 2
IR - Iran 2
KE - Kenya 2
LV - Lettonia 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GF - Guiana Francese 1
GH - Ghana 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
NP - Nepal 1
PS - Palestinian Territory 1
RO - Romania 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
WS - Samoa 1
Totale 6.305
Salva come PNG Salva come JPEG
Città #
Southend 438
Chandler 418
Dallas 328
Singapore 276
Hong Kong 205
Dublin 181
Jacksonville 153
Ashburn 151
Beijing 133
Woodbridge 111
Verona 94
Munich 72
Lawrence 65
Princeton 65
Houston 55
Jinan 55
The Dalles 52
Redmond 49
Wilmington 45
Nanjing 43
Los Angeles 41
Shenyang 39
Helsinki 37
New York 33
Redondo Beach 33
Columbus 28
Buffalo 26
Tianjin 25
Ann Arbor 24
Haikou 24
Redwood City 23
São Paulo 23
Tokyo 21
Hangzhou 20
Santa Clara 20
Changsha 19
Hebei 19
Ningbo 19
Sindelfingen 19
Nanchang 18
Turku 18
Seattle 17
Falkenstein 16
Brussels 15
Washington 14
Milan 13
Zhengzhou 13
Fairfield 12
Rio de Janeiro 12
Brooklyn 11
Lomé 11
Norwalk 11
Nuremberg 11
Taiyuan 11
Taizhou 11
Frankfurt am Main 10
Council Bluffs 9
Fuzhou 9
Lancaster 9
San Francisco 9
Belo Horizonte 8
Falls Church 8
Genoa 8
Lappeenranta 8
Moscow 8
Amsterdam 7
Jakarta 7
Warsaw 7
Chicago 6
Curitiba 6
Dongguan 6
Guangzhou 6
Hyderabad 6
Jiaxing 6
Mexico City 6
Montreal 6
Pignone 6
Algiers 5
Atlanta 5
Düsseldorf 5
Kent 5
London 5
Meda 5
Ottawa 5
Santo André 5
Bologna 4
Cagliari 4
Canoas 4
Dearborn 4
Des Moines 4
Hanoi 4
Minoh 4
Paris 4
Porto Alegre 4
Seoul 4
Tashkent 4
Toronto 4
Asunción 3
Boston 3
Brno 3
Totale 3.954
Salva come PNG Salva come JPEG
Nome #
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 160
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 148
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 143
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 139
Results of a surveillance protocol for pancreatic BD-IPMNs 138
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 138
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 133
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 117
An unforeseeable adverse event during ERCP 114
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 114
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 114
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 113
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 111
Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer 109
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 109
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 107
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 107
Assessment of a complication risk score and study of complication profile in laparoscopic distal pancreatectomy 106
Over 700 Whipples for Pancreaticobiliary Malignancies: Postoperative Morbidity Is an Additional Negative Prognostic Factor for Distal Bile Duct Cancer 106
Pancreatectomy with Para-Aortic Lymph Node Dissection for Pancreatic Head Adenocarcinoma: Pattern of Nodal Metastasis Spread and Analysis of Prognostic Factors 105
Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) 103
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group 103
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 98
Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC) An International Delphi Study Among Patients and Health Care Providers 98
ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 97
Synchronous superior mesenteric-portal vein resection during pancreatectomy for T3 head adenocarcinoma: Perioperative outcomes and prognostic implications of histologically confirmed venous infiltration 95
Assessing the influence of experience in pancreatic surgery: a risk-adjusted analysis using the American College of Surgeons NSQIP database 93
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 92
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 91
The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer 90
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer 88
Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? 87
Pancreatic Adenocarcinoma 87
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications 86
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 83
Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort 81
Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External Validation 80
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 77
Defining the practice of distal pancreatectomy around the world 77
Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery? 75
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma 74
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 73
Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia 73
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 71
Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer 71
Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy 67
Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies 67
ASO Author Reflection: Location of Nodal Metastases in Pancreatoduodenectomy for Cancer: Which Station Matters? 67
Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma 67
Extended Experience with a Dynamic, Data-Driven Selective Drain Management Protocol in Pancreaticoduodenectomy: Progressive Risk Stratification for Better Practice 66
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis 63
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms 61
Response to: Managing the High-risk Pancreatic Anastomosis 61
Intraductal Papillary Mucinous Neoplasm Around the World 61
Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol 61
Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis 60
Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis 59
Trends in practice patterns and outcomes: A decade of sarcoma care in the United States 59
The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy 58
Surgical experience and the practice of pancreatoduodenectomy 57
Response to Comment on "Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma" 55
Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma 54
Response to: "Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation" 53
Impact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database 52
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma 52
The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy 51
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 50
The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy 50
Pasireotide for the Prevention of Postoperative Pancreatic Fistula: Time to Curb the Enthusiasm? 50
Forecasting surgical costs: Towards informed financial consent and financial risk reduction 48
ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better? 47
Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution? 47
Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study 46
Guidelines on Pancreatic Cystic Neoplasms: Major Inconsistencies With Available Evidence and Clinical Practice- Results From an International Survey 45
Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis 45
Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes 41
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review 41
Taking Theory to Practice: Quality Improvement for Pancreaticoduodenectomy and Development and Integration of the Fistula Risk Score 40
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review 33
Outcomes of rescue procedures in the management of locally recurrent ampullary tumors: A Pancreas 2000/EPC study 32
Totale 6.440
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.036
article - articoli 28.101
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 600
patent - brevetti 0
selected - selezionate 0
volume - volumi 335
Totale 58.072
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021355 0 0 0 86 62 83 29 5 13 16 44 17
2021/2022459 45 120 10 24 10 10 12 33 29 16 32 118
2022/20231.168 71 139 102 195 100 300 30 79 106 11 22 13
2023/2024639 26 64 64 65 67 115 54 42 14 18 79 31
2024/20251.623 81 90 54 251 79 34 98 114 229 118 146 329
2025/20261.005 365 218 343 79 0 0 0 0 0 0 0 0
Totale 6.440